Rabeprazole Chloride Compound CAS 153259-31-5 Assay >99.5% (HPLC) Factory

Short Description:

Chemical Name: 2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)pyridine Hydrochloride

Synonyms: Rabeprazole Chloride Compound

CAS: 153259-31-5

Assay: >99.5% (HPLC)

Appearance: Yellowish to Off-White Crystalline Powder

Intermediate of Rebeprazole Sodium CAS 117976-90-6

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Ruifu Chemical Supply Rabeprazole Sodium Intermediates
Rabeprazole Sodium CAS 117976-90-6
Rabeprazole Hydroxy Compound CAS 675198-19-3
Rabeprazole Chloride Compound CAS 153259-31-5

Chemical Properties:

Chemical Name	2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)pyridine Hydrochloride
Synonyms	Rabeprazole Chloride Compound; Rabeprazole Chloro Compound; Rabeprazole 2-Chloromethyl Impurity; 4-(3-Methoxypropoxy)-2-(Chloromethyl)-3-Methylpyridine Hydrochlorid
CAS Number	153259-31-5
CAT Number	RF-PI1918
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C11H17Cl2NO2
Molecular Weight	266.16
Melting Point	113.0~115.0℃
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Yellowish to Off-White Crystalline Powder
Assay / Analysis Method	>99.5% (HPLC)
Loss on Drying	<0.50%
Water (K.F)	<0.50%
Residue on Ignition	<0.20%
Any Single Impurity	<0.50%
Total Impurities	<0.50%
Heavy Metals	<20ppm
Test Standard	Enterprise Standard
Usage	Intermediate of Rebeprazole Sodium (CAS: 117976-90-6)

Rabeprazole Chloride Compound CAS 153259-31-5 Synthetic Route

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

FAQ:

Application:

2-Chloromethyl-3-Methyl-4-(3-Methoxypropoxy)pyridine Hydrochloride, Rabeprazole Chloride Compound (CAS: 153259-31-5) is an intermediate of Rebeprazole Sodium (CAS: 117976-90-6). Rabeprazole Sodium is a anti-ulcer disease drug belonging to proton pump inhibitor and is the sodium salt form of Rabeprazole. The Japanese company Eisai had successfully developed it for the first time with the trade name being “Bolite”. The function of the proton pump inhibitors is reducing the gastric acid secretion so that the lesion site can be stable in order to achieving the effect of curing gastric and duodenal ulcers and stomach-esophageal reflux disease. Clinically it is majorly used for the treatment of acid-related diseases such as stomach and duodenal ulcers, peptic ulcer, gastroesophageal reflux disease and zollinger-ellison syndrome. Rabeprazole is a kind of benzimidazole-substituted compounds. It inhibits the secretion of gastric acid through forming bond with the cytoplasmic proton pump in the gastric cavity wall. This product can specifically inhibit the effect of the adenosine triphosphatase that is the key enzyme during the production of stomach acid. It has inhibitory effect on both basal gastric acid and the gastric acid secretion caused by the stimulation.